News
Category
-
PR Newswire
Carrot Fertility Partners with CCRM Fertility Expanding Member Access to High-Quality Fertility Care
September 15, 2020 -
PR Newswire
Innovent and Lilly Jointly Announce Results of Six Clinical Studies of TYVYT® (sintilimab injection) to be Presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
September 14, 2020 -
News Medical Life Sciences
Insilico Medicine launches new system for COVID-19 basic and clinical research
September 9, 2020 -
GlobeNewswire
Precision BioSciences Receives Fast Track Designation from U.S. Food and Drug Administration for PBCAR269A, an Investigational Allogeneic CAR T Therapy for Relapsed/Refractory Multiple Myeloma
September 9, 2020 -
GlobeNewswire
Conduent Teams Up with Buoy Health and IBM Watson Health to Help its Clients Manage COVID-19 Related Workplace Challenges
September 9, 2020 -
PR Newswire
Avidity Biosciences Enters into Collaboration to Study the Natural History of Myotonic Dystrophy Type 1
September 8, 2020 -
Business Wire
Caribou Biosciences Announces FDA Clearance of its IND for CB-010, an Off-the-shelf Allogeneic Anti-CD19 CAR-T Cell Therapy
September 8, 2020 -
STAT
Blueprint Medicines wins U.S. approval for genetically targeted lung cancer drug
September 5, 2020 -
PR Newswire
Innovent Announces NMPA Granted Marketing Approval for SULINNO® (Adalimumab Injection) in China
September 3, 2020 -
PR Newswire
Sana Biotechnology Strengthens Senior Research Leadership Team with Ed Rebar, Ph.D. and Terry Fry, M.D.
September 3, 2020 -
Business Wire
Rallybio Appoints Helen M. Boudreau to Board of Directors
September 3, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Additional Interim Results from Proof-of-Concept Study of OTL-203 for MPS-I
September 1, 2020 -
PR Newswire
Nocion Therapeutics Advances to Clinical Stage and Expands Leadership
September 1, 2020 -
PR Newswire
Innovent Announces First Subject Dosed in the Phase 1 Clinical Trial of Anti-IL-23 Monoclonal Antibody
August 31, 2020 -
PR Newswire
Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO
August 31, 2020 -
PR Newswire
Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference
August 30, 2020 -
The Irish Times
Irish company among tech firms at forefront of fight against coronavirus
August 27, 2020 -
PR Newswire
EY Announces Nick Culbertson of Protenus as an Entrepreneur of the Year® 2020 Mid-Atlantic Award Finalist
August 27, 2020 -
PR Newswire
MedGenome announces Strategic Collaboration in Parkinson’s Disease with Denali Therapeutics
August 26, 2020 -
GlobeNewswire
Kin Insurance Selects Snapsheet to Deploy End-to-End Claims Management Platform
August 25, 2020 -
Business Wire
Compass Therapeutics Announces Publication in the Journal Science of Preclinical Data Supporting the Potential of CTX-2026, a Novel Antibody to the Butyrophilin BTN3A1, in Ovarian Cancer Tumor Models
August 24, 2020 -
Business Wire
Lyniate and PatientPing Form Strategic Partnership to Ensure Compliance with the CMS E-Notifications Requirements
August 19, 2020 -
GlobeNewswire
Precision BioSciences Receives Fast Track Disease Designation from U.S. Food and Drug Administration for PBCAR0191 Investigational Allogeneic CAR T Cell Therapy
August 19, 2020 -
PR Web
Snapdocs Announces Lender Point of Sale Integration to Streamline Homebuying Experience for Borrowers
August 19, 2020 -
PR Newswire
Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement
August 18, 2020 -
Business Wire
Ivenix Features Smart Pump Interoperability with Epic, Advancing Patient Outcomes and Clinical Efficiency
August 18, 2020 -
Fortune
Carrot Fertility closes $24 million Series B in a sign of the sector’s strength
August 18, 2020 -
PR Newswire
Buoy Health Selected as Preferred Partner in AI Enhanced Symptom Checker/ Digital Front Door Category by Consortium Health Plans
August 17, 2020 -
Business News Asia
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
August 17, 2020 -
GlobeNewswire
Arvelle Announces Partnership with Durbin Across Europe
August 17, 2020 -
PR Newswire
Buoy Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance
August 13, 2020 -
GlobeNewswire
Recurly Secures Majority Equity Investment From Accel-KKR
August 12, 2020 -
PR Newswire
Whatfix Simplifies BMC Helix Adoption
August 12, 2020 -
GlobeNewswire
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results
August 12, 2020 -
PR Newswire
PatientPing and Real Time Medical Systems Join Forces to Prevent High-Risk Patient Readmissions for Post-Acute Care and Skilled Nursing Facilities
August 11, 2020 -
PR Newswire
Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium
August 8, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering
August 7, 2020 -
Endpoints News
Biogen hands Denali $1B-plus in cash, $1B-plus in milestones to partner on late-stage Parkinson’s drug
August 6, 2020 -
PR Newswire
Robert Margolis, MD Joins WelbeHealth Board of Directors
August 6, 2020 -
TheStreet
IPO Launch: Checkmate Pharmaceuticals Proposes $75 Million IPO
August 4, 2020 -
Fierce Healthcare
Quartet taps SilverCloud Health to broaden access to digital mental health services
August 4, 2020 -
GlobeNewswire
Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors
August 3, 2020 -
GlobeNewswire
Oxford Biomedica Signs Development, Manufacture & License Agreement with Beam Therapeutics Inc., for LentiVector® Platform for Next Generation CAR-T Therapeutics
August 3, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
August 2, 2020 -
Business Wire
SonderMind and Varsity Tutors Team Up to Help Families and Kids with Well-Being During a Disrupted School Year
July 30, 2020 -
China Knowledge
Eyebright Medical Technology’s IPO debut on SSE STAR Market today
July 29, 2020 -
GlobeNewswire
Denali Therapeutics Announces Phase 1b Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in COVID-19 Patients
July 29, 2020 -
PR Newswire
Avidity Biosciences Appoints Jae Kim, M.D. as Chief Medical Officer
July 28, 2020 -
Business Wire
Checkmate Pharmaceuticals Granted FDA Fast Track Designation for CMP-001 Combined with PD-1 Blockade in the Treatment of Certain Types of Metastatic or Unresectable Melanoma
July 27, 2020 -
GlobeNewswire
Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®
July 27, 2020 -
PR Newswire
Blueprint Medicines Receives Positive CHMP Opinion for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
July 24, 2020 -
Genetic Engineering & Biotechnology News
Orchard Therapeutics Inks Deal for GSK’s Stable Cell Line Technology
July 23, 2020 -
GlobeNewswire
Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma
July 23, 2020 -
Business Wire
Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors
July 23, 2020 -
GlobeNewswire
Interos and RiskRecon Identify Vulnerable and Hidden Third, Fourth, and Fifth Party Suppliers
July 22, 2020 -
GlobeNewswire
Ultragenyx Announces U.S. Commercial Launch of Dojolvi™ (triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
July 22, 2020 -
GlobeNewswire
Flywire Helps Education Agents and Institutions Streamline International Tuition Payments
July 21, 2020 -
PR Newswire
Everest Group Recognizes Whatfix as a Leader in Digital Adoption Platforms PEAK Matrix Report 2020
July 21, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designations for OTL-203 for the Treatment of MPS-I
July 21, 2020 -
Business Wire
SonderMind Announces Therapist Network Expansion in Ohio
July 20, 2020 -
FierceBiotech
COVID-19 close-up: Nocion CEO Batycky on controlling cough to control spread
July 16, 2020 -
PR Newswire
Centene and Quartet Health expand partnership nationwide to help ensure members have access to critical behavioral health care during COVID-19 pandemic and beyond
July 16, 2020 -
FierceBiotech
New Insilico Medicine spinout to tackle longevity, COVID-19
July 15, 2020 -
PR Newswire
Even Financial Achieves SOC 2 Type I Compliance
July 15, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
July 15, 2020 -
GlobeNewswire
Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV
July 15, 2020 -
Deal Street Asia
China’s Citrine Medicine closes $80m in Series A Round
July 14, 2020 -
The Motley Fool
Blueprint Medicines Inks Deal With Roche Worth Up to $1.7 Billion
July 14, 2020 -
PR Newswire
Protenus Selected as One of the Best Places to Work in Healthcare for Third Consecutive Year
July 14, 2020 -
GlobeNewswire
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
July 9, 2020 -
Xconomy
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep
July 9, 2020 -
Kyruus
SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
July 8, 2020 -
Reuters
Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals
July 7, 2020 -
GlobeNewswire
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
July 6, 2020 -
GlobeNewswire
Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedation
July 2, 2020 -
Crunchbase
French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More Collaborative
July 1, 2020 -
PR Newswire
Blueprint Medicines Announces Submission of New Drug Application to FDA for Pralsetinib for the Treatment of Advanced RET Mutant and RET Fusion-Positive Thyroid Cancers
July 1, 2020 -
Business Wire
Kyruus Obtains AVIA Recognition for Its Enterprise-Wide Patient Access Platform
July 1, 2020 -
ACN Newswire
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of Dorzagliatin
July 1, 2020 -
GlobeNewswire
Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders
June 30, 2020 -
Business Wire
Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting
June 27, 2020 -
GlobeNewswire
Flywire’s New International Payment Plan Options Help Improve Tuition Affordability During COVID-19
June 25, 2020 -
PR Newswire
OTA Insight shapes the future of real-time market intelligence with Market Insight
June 25, 2020 -
PR Newswire
PatientPing Launches Route Solution to Guarantee Hospital E-Notifications Condition of Participation Compliance Under CMS’s Interoperability and Patient Access Rule
June 24, 2020 -
Business Wire
Compass Therapeutics Completes Reverse Merger and Closes $60 Million Private Placement
June 24, 2020 -
PR Newswire
TraceLink Announces Results from FDA DSCSA Pilot Program
June 23, 2020 -
PR Newswire
Sana Biotechnology Announces Completion Of Initial Financing
June 23, 2020 -
GlobeNewswire
Flywire Announces Charitable Foundation to Help Improve Global Equality
June 23, 2020 -
GlobeNewswire
Snapsheet Streamlines Outdoorsy’s Operations, Supports Growth through Digital Transformation
June 22, 2020 -
GlobeNewswire
Tempest Therapeutics Announces First Patient Dosed With the Combination of TPST-1120 Plus Nivolumab in a Phase 1 Study in Patients With Advanced Solid Tumors
June 22, 2020